Drug Profile
Glutamine - BioKier
Alternative Names: BKR-013; L-glutamine - BioKierLatest Information Update: 07 Dec 2022
Price :
$50
*
At a glance
- Originator BioKier
- Class Anti-inflammatories; Antianaemics; Antihyperglycaemics; Basic amino acids; Diamino amino acids; Neutral amino acids; Small molecules
- Mechanism of Action Protein synthesis modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 07 Dec 2022 No development reported - Phase-II for Type 2 diabetes mellitus in USA (PO)
- 28 Jun 2019 No recent reports of development identified for phase-I development in Type-2-diabetes-mellitus in USA (Rectal, Suppository)
- 30 Jun 2018 BioKier completes a phase II trial in Type-2 diabetes mellitus in USA (PO) (NCT03382015)